Original language | English |
---|---|
Pages (from-to) | 2467-2469 |
Number of pages | 3 |
Journal | Journal of the American College of Cardiology |
Volume | 79 |
Issue number | 24 |
DOIs | |
State | Published - 21 Jun 2022 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American College of Cardiology, Vol. 79, No. 24, 21.06.2022, p. 2467-2469.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Right Precordial U Waves in Severe Aortic Stenosis
T2 - “Real-World” Prevalence and Diminution by TAVR
AU - Lampert, Joshua
AU - Pulaski, Matthew
AU - Miller, Marc A.
AU - Whang, William
AU - Koruth, Jacob
AU - Glicksberg, Benjamin
AU - Sharma, Samin
AU - Dukkipati, Srinivas R.
AU - Fuster, Valentin
AU - Reddy, Vivek Y.
N1 - Funding Information: Dr Reddy has served as a consultant for Abbott Biosense-Webster, BioTel Heart, Biotronik, Boston Scientific, CardioFocus, Cardionomic, EBR, Fire1, Gore & Associates, Impulse Dynamics, Medtronic, Philips, Pulse Biosciences, and Thermedical; has served as a consultant for and has equity in Ablacon, Acutus Medical, Affera, Apama Medical, APN Health, Aquaheart, AtaCor, Autonomix, Axon Therapeutics, Backbeat, BioSig, Cardiac Implants, CardiaCare, CardioNXT/AFTx, Circa Scientific, Corvia Medical, Dinova-Hangzhou Nuomao Medtech Co, Ltd, East End Medical, EPD, EPIX Therapeutics, EpiEP, Eximo, Farapulse, HRT, Intershunt, Javelin, Kardium, Keystone Heart, LuxMed, MedLumics, Middlepeak, Nuvera, Sirona Medical, and Valcare; and has equity in Manual Surgical Sciences, Newpace, Surecor, and Vizaramed, all unrelated to this paper. Dr Dukkipati has a research grant from Biosense Webster; and holds equity in Manual Surgical Sciences and Farapulse. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Jessica Torres Soto, BS, served as Guest Associate Editor for this paper. Athena Poppas, MD, served as Guest Editor-in-Chief for this paper. Funding Information: Dr Reddy has served as a consultant for Abbott Biosense-Webster, BioTel Heart, Biotronik, Boston Scientific, CardioFocus, Cardionomic, EBR, Fire1, Gore & Associates, Impulse Dynamics, Medtronic, Philips, Pulse Biosciences, and Thermedical; has served as a consultant for and has equity in Ablacon, Acutus Medical, Affera, Apama Medical, APN Health, Aquaheart, AtaCor, Autonomix, Axon Therapeutics, Backbeat, BioSig, Cardiac Implants, CardiaCare, CardioNXT/AFTx, Circa Scientific, Corvia Medical, Dinova-Hangzhou Nuomao Medtech Co, Ltd, East End Medical, EPD, EPIX Therapeutics, EpiEP, Eximo, Farapulse, HRT, Intershunt, Javelin, Kardium, Keystone Heart, LuxMed, MedLumics, Middlepeak, Nuvera, Sirona Medical, and Valcare; and has equity in Manual Surgical Sciences, Newpace, Surecor, and Vizaramed, all unrelated to this paper. Dr Dukkipati has a research grant from Biosense Webster; and holds equity in Manual Surgical Sciences and Farapulse. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Jessica Torres Soto, BS, served as Guest Associate Editor for this paper. Athena Poppas, MD, served as Guest Editor-in-Chief for this paper.
PY - 2022/6/21
Y1 - 2022/6/21
UR - http://www.scopus.com/inward/record.url?scp=85131758731&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2022.04.012
DO - 10.1016/j.jacc.2022.04.012
M3 - Letter
C2 - 35490926
AN - SCOPUS:85131758731
SN - 0735-1097
VL - 79
SP - 2467
EP - 2469
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 24
ER -